Anzeige
Mehr »
Login
Donnerstag, 18.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Kurze Gold-Preis-Konsolidierung zum Einstieg in diese Aktie nutzen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
60 Leser
Artikel bewerten:
(0)

Active-Investors: Free Post Earnings Research Report: Eastman Chemical's Quarterly EPS Increased 7.28%; Surpassed Expectations

Stock Monitor: Rayonier Advanced Materials Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 22, 2018 / Active-Investors.com has just released a free earnings report on Eastman Chemical Co. (NYSE: EMN). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/'symbol=EMN. The Company reported its financial results on February 01, 2018, for the quarter ended and full year ended December 31, 2017. The Company demonstrated a strong performance in Q4 FY17 and fiscal 2017, driven by the strength of its portfolio and the benefits of its innovation-driven growth model. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Rayonier Advanced Materials Inc. (NYSE: RYAM), which also belongs to the Basic Materials sector as the Company Eastman Chemical. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/'symbol=RYAM

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Eastman Chemical most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/'symbol=EMN

Earnings Highlights and Summary

For the fourth quarter of FY17, Eastman Chemical's total revenues reached $2.36 billion, up 7.95% from $2.19 billion in Q4 FY16, led by a strong growth of high-margin products in its specialty businesses. The Company's revenue numbers were higher than analysts'consensus estimates of $2.29 billion.

Eastman Chemical's total operating expenses decreased 4.20% to $228 million in Q4 FY17 from $238 million in Q4 FY16. This was mainly led by a reduction in research and development (R&D) expenses, and asset impairment and restructuring charges. The Company's operating income was $268 million for the reported quarter, a y-o-y growth of 6.35%. Eastman Chemical's adjusted operating income, excluding non-core and unusual items, was $354 million, up 5.36% y-o-y.

The Company's net earnings attributable to common shareholders were $581 million for the reported quarter compared to $116 million in the year ago same quarter. The Company's diluted earnings per share (EPS) also rose to $4.01 in Q4 FY17 from $0.79 in Q4 FY16, a change of approximately 407.59%. The reported numbers included costs of $0.55 per diluted share resulting from a coal gasification incident, and a net benefit of $2.91 per share from the enactment of the Tax Cuts and Jobs Act 2017 (TCJA). The Company's adjusted diluted EPS, excluding non-recurring and non-core items, came in at $1.62 in Q4 FY17, up from $1.51 in Q4 FY16, reflecting a change of 7.28%. The earnings numbers surpassed analysts' estimates of $1.06 per share.

For the year ended December 31, 2017, Eastman Chemical's total revenues were $9.55 billion, up 6.01% from $9.01 billion in FY16. Eastman Chemical's net earnings attributable to common shareholders advanced 72.60% to $1.47 billion in the year under review from $854 million in the previous year. The Company's diluted EPS also rose to $10.09 in FY17 from $5.75 in FY16, reflecting a change of 75.48%. For FY17, the Company's adjusted diluted EPS, excluding non-recurring and non-core items, were $7.61; an increase of 12.57% from $6.76 in FY16.

Segment Details

During Q4 2017, Eastman Chemical's Additives and Functional Products segment's net revenues jumped 18.61% to $854 million on a y-o-y basis, mainly due to higher sales volumes for most product lines, favorable currency swings, and increased selling prices. The segment's operating earnings were $149 million in Q4 FY17, 24.17% higher than $120 million in Q4 FY16. The segment's adjusted operating earnings were $160 million for the reported quarter compared to $132 million for the same period of last year, reflecting a y-o-y change of 21.21%.

For Q4 FY17, Eastman Chemical's Advanced Materials segment's net revenues advanced 8.73% to $635 million on a y-o-y basis. Approximately 6% of the revenue growth in this segment was attributed to a volume/product mix effect. In the reported quarter, the segment's operating income decreased 7.78% to $83 million y-o-y, mainly due to net costs resulting from the coal gasification incident. The Advanced Materials segment's adjusted operating income increased 4.44% to $94 million in Q4 FY17 from $90 million in Q4 FY16.

During Q4 FY17, Eastman Chemical's Chemical Intermediates segment's net revenues increased 2.49% to $659 million y-o-y, due to higher selling prices and improved market conditions. For Q4 FY17, the segment's operating income was $9 million, a y-o-y decrease of 82%, mainly due to additional costs of $44 million from the coal gasification incident. The segment's adjusted operating income increased to $53 million in Q4 FY17 from $50 million in the same period of 2016.

In Q4 FY17, Eastman Chemical's Fibers segment's net revenues fell 13.04% to $200 million y-o-y, due to lower selling prices and volumes, especially for acetate tow. In the reported quarter, the segment's operating income decreased 97.26% to $2 million y-o-y, mainly due to net costs of $49 million from the coal gasification incident. The segment's adjusted operating income fell 30.14% to 51 million in Q4 FY17 from $73 million in Q4 FY16.

Cash Matters

Eastman Chemical had cash and cash equivalents of $191 million as on December 31, 2017, compared to $181 million as on December 31, 2016. The Company's total borrowings were $6.43 billion as on December 31, 2017, compared to $6.59 billion as on December 31, 2016.

For the quarter ended December 31, 2017, Eastman Chemical's net cash flow from operating activities was $646 million compared to $390 million for the same period in 2016. The Company's adjusted free cash flow was $435 million for Q4 FY17 compared to $289 million in Q4 FY16.

In 2017, the Company returned nearly $646 million to its stockholders in the form of dividends of $296 million and share repurchases of $350 million. The Company also repaid debt of $350 million in the year under review, with total borrowings reduced by $163 million, including the negative impact of currency translation on the carrying value of euro-denominated borrowings.

Outlook

Eastman Chemical expects its growth momentum to continue in 2018 owing to its growth-oriented investments, high-margin products, and innovation. The Company expects an adjusted EPS growth of 8% - 12% in 2018.

Stock Performance Snapshot

February 21, 2018 - At Wednesday's closing bell, Eastman Chemical's stock slightly climbed 0.80%, ending the trading session at $101.09.

Volume traded for the day: 1.01 million shares.

Stock performance in the last month - up 3.40%; previous three-month period - up 12.65%; past twelve-month period - up 24.91%; and year-to-date - up 9.12%

After yesterday's close, Eastman Chemical's market cap was at $14.53 billion.

Price to Earnings (P/E) ratio was at 9.99.

The stock has a dividend yield of 2.22%.

The stock is part of the Basic Materials sector, categorized under the Chemicals - Major Diversified industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.